Personally, I would imagine that company would want to have the pending deal for licensees for Progenza in Japan well and truly in place prior to the AGM. Might be a chilly room if not.
So - late October/Early November a target IMO.
RGS Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held